Literature DB >> 22398058

Mortality in ulcerative colitis and Crohn's disease. A population-based study in Finland.

Pia Manninen1, Anna-Liisa Karvonen, Heini Huhtala, Martin Rasmussen, Maarit Salo, Leena Mustaniemi, Ismo Pirttiniemi, Pekka Collin.   

Abstract

BACKGROUND: An increased mortality has been reported in patients with Crohn's disease (CD), while figures have remained similar or decreased in patients with ulcerative colitis (UC) compared to the population in general. We evaluated the long-term mortality risk of patients with inflammatory bowel diseases (IBD) in a well-defined population.
METHODS: The data were based on a prospective IBD register in our catchment area; follow-up covered 1986-2007. The population based cohort comprised 1915 adult patients, 1254 with UC, 550 with CD, and 111 with inflammatory bowel disease unclassified (IBDU). The mortality rate and causes of death were obtained from Statistics Finland.
RESULTS: We recorded 223 deaths among the 1915 patients with IBD within a follow-up of 29,644 person-years. The standardised mortality rate (SMR) was 1.14 in CD and 0.90 in UC. In cause-specific mortality; the risk of death in diseases of the digestive system was significantly increased in CD (SMR 5.38). The mortality in colorectal cancer was non-significantly increased in both UC and CD (SMR 1.80 and 1.88, respectively). Compared to the background population, there were significantly fewer deaths due to mental and behavioural disorders due to use of alcohol (0 observed, 10.2 expected in IBD).
CONCLUSIONS: The overall mortality in CD and CU was not different from that in the population. In cause-specific mortality, diseases of the digestive system were significantly increased. Deaths due to mental and behavioural disorders resulting from alcohol consumption were less common in patients with IBD than in the population at large in Finland.
Copyright © 2011 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22398058     DOI: 10.1016/j.crohns.2011.10.009

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  19 in total

Review 1.  Association between NCF4 rs4821544T/C polymorphism and inflammatory bowel disease risk in Caucasian: a meta-analysis.

Authors:  Peng-Bo Wu; Jin-Fen Dai; Qian Wang; Guo Zhang; Shi-Yun Tan; Ming Li; Hui-Lan Ye
Journal:  Inflamm Res       Date:  2015-08-20       Impact factor: 4.575

Review 2.  Inflammatory Bowel Disease.

Authors:  Jan Wehkamp; Martin Götz; Klaus Herrlinger; Wolfgang Steurer; Eduard F Stange
Journal:  Dtsch Arztebl Int       Date:  2016-02-05       Impact factor: 5.594

3.  Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review.

Authors:  Mathurin Fumery; Siddharth Singh; Parambir S Dulai; Corinne Gower-Rousseau; Laurent Peyrin-Biroulet; William J Sandborn
Journal:  Clin Gastroenterol Hepatol       Date:  2017-06-16       Impact factor: 11.382

Review 4.  Understanding the Cautions and Contraindications of Immunomodulator and Biologic Therapies for Use in Inflammatory Bowel Disease.

Authors:  H Matthew Cohn; Maneesh Dave; Edward V Loftus
Journal:  Inflamm Bowel Dis       Date:  2017-08       Impact factor: 5.325

Review 5.  The Natural History of IBD: Lessons Learned.

Authors:  Petra Weimers; Pia Munkholm
Journal:  Curr Treat Options Gastroenterol       Date:  2018-03

Review 6.  Predictive factors for a severe clinical course in ulcerative colitis: Results from population-based studies.

Authors:  Magnus Hofrenning Wanderås; Bjørn A Moum; Marte Lie Høivik; Øistein Hovde
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

7.  No association of alcohol use and the risk of ulcerative colitis or Crohn's disease: data from a European Prospective cohort study (EPIC).

Authors:  M M Bergmann; V Hernandez; W Bernigau; H Boeing; S S M Chan; R Luben; K-T Khaw; F van Schaik; B Oldenburg; B Bueno-de-Mesquita; K Overvad; D Palli; G Masala; F Carbonnel; M-C Boutron-Ruault; A Olsen; A Tjonneland; R Kaaks; V Katzke; E Riboli; A R Hart
Journal:  Eur J Clin Nutr       Date:  2017-01-25       Impact factor: 4.016

8.  Sexual function and patients' perceptions in inflammatory bowel disease: a case-control survey.

Authors:  Laura Marín; Míriam Mañosa; Esther Garcia-Planella; Jordi Gordillo; Yamile Zabana; Eduard Cabré; Eugeni Domènech
Journal:  J Gastroenterol       Date:  2012-11-03       Impact factor: 7.527

Review 9.  Inflammatory bowel disease course in Crohn's disease: is the natural history changing?

Authors:  Petra A Golovics; Michael D Mandel; Barbara D Lovasz; Peter L Lakatos
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

Review 10.  Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis.

Authors:  Bruno César da Silva; Andre Castro Lyra; Raquel Rocha; Genoile Oliveira Santana
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.